211 related articles for article (PubMed ID: 21572449)
1. Trichosanthin enhances anti-tumor immune response in a murine Lewis lung cancer model by boosting the interaction between TSLC1 and CRTAM.
Cai Y; Xiong S; Zheng Y; Luo F; Jiang P; Chu Y
Cell Mol Immunol; 2011 Jul; 8(4):359-67. PubMed ID: 21572449
[TBL] [Abstract][Full Text] [Related]
2. The tumor suppressor TSLC1/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAM.
Boles KS; Barchet W; Diacovo T; Cella M; Colonna M
Blood; 2005 Aug; 106(3):779-86. PubMed ID: 15811952
[TBL] [Abstract][Full Text] [Related]
3. Trichosanthin inhibits DNA methyltransferase and restores methylation-silenced gene expression in human cervical cancer cells.
Huang Y; Song H; Hu H; Cui L; You C; Huang L
Mol Med Rep; 2012 Oct; 6(4):872-8. PubMed ID: 22825485
[TBL] [Abstract][Full Text] [Related]
4. Trichosanthin induced Th2 polarization status.
Zhao S; Wang Y; Wei H
Cell Mol Immunol; 2006 Aug; 3(4):297-301. PubMed ID: 16978539
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Th1- and enhancement of Th2-initiating cytokines and chemokines in trichosanthin- treated macrophages.
Xu W; Hou W; Yao G; Ji Y; Yeh M; Sun B
Biochem Biophys Res Commun; 2001 Jun; 284(1):168-72. PubMed ID: 11374886
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor in lung cancer 1 (TSLC1), a novel tumor suppressor gene, is implicated in the regulation of proliferation, invasion, cell cycle, apoptosis, and tumorigenicity in cutaneous squamous cell carcinoma.
Liu D; Feng X; Wu X; Li Z; Wang W; Tao Y; Xia Y
Tumour Biol; 2013 Dec; 34(6):3773-83. PubMed ID: 23812766
[TBL] [Abstract][Full Text] [Related]
7. CRTAM receptor engagement by Necl-2 on tumor cells triggers cell death of activated Vγ9Vδ2 T cells.
Dessarthe B; Thedrez A; Latouche JB; Cabillic F; Drouet A; Daniel P; de La Pintière CT; Catros V; Toutirais O
J Immunol; 2013 May; 190(9):4868-76. PubMed ID: 23530148
[TBL] [Abstract][Full Text] [Related]
8. CRTAM controls residency of gut CD4+CD8+ T cells in the steady state and maintenance of gut CD4+ Th17 during parasitic infection.
Cortez VS; Cervantes-Barragan L; Song C; Gilfillan S; McDonald KG; Tussiwand R; Edelson BT; Murakami Y; Murphy KM; Newberry RD; Sibley LD; Colonna M
J Exp Med; 2014 Apr; 211(4):623-33. PubMed ID: 24687959
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of GM-CSF-producing tumor vaccine after docetaxel chemotherapy in mice bearing established Lewis lung carcinoma.
Chu Y; Wang LX; Yang G; Ross HJ; Urba WJ; Prell R; Jooss K; Xiong S; Hu HM
J Immunother; 2006; 29(4):367-80. PubMed ID: 16799332
[TBL] [Abstract][Full Text] [Related]
10. CRTAM determines the CD4+ cytotoxic T lymphocyte lineage.
Takeuchi A; Badr Mel S; Miyauchi K; Ishihara C; Onishi R; Guo Z; Sasaki Y; Ike H; Takumi A; Tsuji NM; Murakami Y; Katakai T; Kubo M; Saito T
J Exp Med; 2016 Jan; 213(1):123-38. PubMed ID: 26694968
[TBL] [Abstract][Full Text] [Related]
11. Trichosanthin Promotes Anti-Tumor Immunity through Mediating Chemokines and Granzyme B Secretion in Hepatocellular Carcinoma.
Wang K; Wang X; Zhang M; Ying Z; Zhu Z; Tam KY; Li C; Zhou G; Gao F; Zeng M; Sze SCW; Wang X; Sha O
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674931
[TBL] [Abstract][Full Text] [Related]
12. Adoptive transfer of anti-CD3-activated CD4+ T cells plus cyclophosphamide and liposome-encapsulated interleukin-2 cure murine MC-38 and 3LL tumors and establish tumor-specific immunity.
Saxton ML; Longo DL; Wetzel HE; Tribble H; Alvord WG; Kwak LW; Leonard AS; Ullmann CD; Curti BD; Ochoa AC
Blood; 1997 Apr; 89(7):2529-36. PubMed ID: 9116299
[TBL] [Abstract][Full Text] [Related]
13. Characterization of CRTAM gene promoter: AP-1 transcription factor control its expression in human T CD8 lymphocytes.
Valle-Rios R; Patiño-Lopez G; Medina-Contreras O; Canche-Pool E; Recillas-Targa F; Lopez-Bayghen E; Zlotnik A; Ortiz-Navarrete V
Mol Immunol; 2009 Oct; 46(16):3379-87. PubMed ID: 19695707
[TBL] [Abstract][Full Text] [Related]
14. Combined dendritic cell cryotherapy of tumor induces systemic antimetastatic immunity.
Machlenkin A; Goldberger O; Tirosh B; Paz A; Volovitz I; Bar-Haim E; Lee SH; Vadai E; Tzehoval E; Eisenbach L
Clin Cancer Res; 2005 Jul; 11(13):4955-61. PubMed ID: 16000595
[TBL] [Abstract][Full Text] [Related]
15. Trichosanthin inhibits breast cancer cell proliferation in both cell lines and nude mice by promotion of apoptosis.
Fang EF; Zhang CZ; Zhang L; Wong JH; Chan YS; Pan WL; Dan XL; Yin CM; Cho CH; Ng TB
PLoS One; 2012; 7(9):e41592. PubMed ID: 22957017
[TBL] [Abstract][Full Text] [Related]
16. PD-1 blockade enhances radio-immunotherapy efficacy in murine tumor models.
Zhuang Y; Li S; Wang H; Pi J; Xing Y; Li G
J Cancer Res Clin Oncol; 2018 Oct; 144(10):1909-1920. PubMed ID: 30074066
[TBL] [Abstract][Full Text] [Related]
17. Trichosanthin-induced autophagy in gastric cancer cell MKN-45 is dependent on reactive oxygen species (ROS) and NF-κB/p53 pathway.
Wei B; Huang Q; Huang S; Mai W; Zhong X
J Pharmacol Sci; 2016 Jun; 131(2):77-83. PubMed ID: 27032906
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells engineered to express GITRL enhance therapeutic immunity in murine Lewis lung carcinoma.
Ma J; Wang S; Ma B; Mao C; Tong J; Yang M; Wu C; Jiao Z; Lu L; Xu H
Cancer Lett; 2011 Feb; 301(2):142-50. PubMed ID: 21186078
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Targeted Gene Silencing IDO Synergizes PTT-Induced Apoptosis and Enhances Anti-tumor Immunity.
Zhang Y; Feng Y; Huang Y; Wang Y; Qiu L; Liu Y; Peng S; Li R; Kuang N; Shi Q; Shi Y; Chen Y; Joshi R; Wang Z; Yuan K; Min W
Front Immunol; 2020; 11():968. PubMed ID: 32582152
[No Abstract] [Full Text] [Related]
20. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
[Next] [New Search]
